BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8618588)

  • 1. Chronic viral hepatitis--benefits of current therapies.
    Hoofnagle JH; Lau D
    N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
    Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
    N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous steroids/interferon therapy in chronic hepatitis B.
    Causse X; Godinot H; Chevallier M; Chossegros P; Zoulim F; Zarski JP; Meschiewitz C; Albrecht J; Trépo C
    J Hepatol; 1993 Jan; 17(1):128-9. PubMed ID: 8445212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term follow-up of HBeAg-positive patients after interferon-alpha treatment for chronic hepatitis B].
    Goeser T
    Z Gastroenterol; 1997 Mar; 35(3):233-5. PubMed ID: 9173693
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic hepatitis B with interferon alpha-2b].
    Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
    Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
    Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C
    Prog Clin Biol Res; 1991; 364():399-404. PubMed ID: 2020715
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interferon treatment in chronic hepatitis B].
    Pastore G; Santantonio T; Milella M; Iacovazzi T; Longo A; Pietromatera G
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):97-102. PubMed ID: 7619970
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
    Bayraktar Y; Uzunalimoglu B; Arslan S; Koseoglu T; Kayhan B; Telatar H
    Gut; 1993; 34(2 Suppl):S101. PubMed ID: 8314468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon therapy in chronic viral hepatitis].
    Welland O
    Nord Med; 1992; 107(3):72-3, 75. PubMed ID: 1549455
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B virus replication patterns after orthotopic liver transplantation: de novo versus recurrent infection.
    Douglas DD; Rakela J; Taswell HF; Krom RA; Wiesner RH
    Transplant Proc; 1993 Apr; 25(2):1755-7. PubMed ID: 8470154
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B viral kinetics: a dynamic puzzle still to be resolved.
    Neumann AU
    Hepatology; 2005 Aug; 42(2):249-54. PubMed ID: 16025494
    [No Abstract]   [Full Text] [Related]  

  • 14. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Giustina G; Pedini B; Alberti A
    Arch Virol Suppl; 1992; 4():291-3. PubMed ID: 1450705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-interferon treatment of chronic hepatitis B infection: predictors of responsiveness.
    Dusheiko GM
    J Gastroenterol Hepatol; 1991; 6 Suppl 1():7-12. PubMed ID: 1751802
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing.
    Perrillo R; Mimms L; Schechtman K; Robbins D; Campbell C
    Hepatology; 1993 Dec; 18(6):1306-12. PubMed ID: 8244253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of interferon alpha in treatment of chronic viral hepatitis B].
    Bauer B
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):282-3. PubMed ID: 8234044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.